Rigicon, Inc.

• 0Reports naming them
• 1Markets in public records
• 0Regions & countries
• 2Active trials they lead^[1]

^[1] ClinicalTrials.gov, Studies led by Rigicon, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.

Public data

Free public data on Rigicon, Inc.

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Company facts

Website

rigicon.com

Type

Medical devices

Source: Wikidata, Company record Q141595822. Retrieved 13 Nov 2026.

Clinical trials

2 active studies led by Rigicon, Inc., of 3 in all

Source: ClinicalTrials.gov, Studies with Rigicon, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.

See them on ClinicalTrials.gov (opens in a new tab)

US device clearances

1 510(k) clearances and PMA approvals since 2015

• Rigi10 Malleable Penile Prosthesis K181673 · 15 Apr 2019

Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.

See them on openFDA (opens in a new tab)

Trials over time

Studies Rigicon, Inc. leads, by the year they started and their phase

2 2025

1 2026

• Phase 1
• Phase 2
• Phase 3
• Phase 4
• No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with Rigicon, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Markets where public records show them

Markets we cover where free public records show Rigicon, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

• Erectile Dysfunction Treatment

Search all reports for Rigicon, Inc. All companies